Inspiratory Flow and Volumes in Bronchiectatics

Syntara

Status: Completed

Conditions: Bronchiectasis

Study type: Observational

Funder types: Industry

Identifiers

NCT00656565

DPM-OSM-402

Details and patient eligibility

About

Adequate administration of drugs via dry powder inhalers is dependent on adequate inspiratory flow rates and volumes. These vary according to the device being used and its resistance. The dry powder inhaler device under investigation is a device approved by the Therapeutic Goods Administration (ARTG no. 196255) for use with dry powder mannitol. Dry powder mannitol is currently being investigated as a treatment for bronchiectasis. We wish to measure the inspiratory flow characteristics of both the low and high resistance devices amongst a group of subjects with bronchiectasis.

We propose that the majority of subjects investigated with varying lung function will achieve adequate flow during a controlled inspiration.

Enrollment: 15 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• non-cf bronchiectasis
• aged 18-80 inclusive
• FEV1 greater or equal to 50% predicted and greater or equal to 1L

Exclusion criteria

• uncontrolled asthma
• CF bronchiectasis
• have any condition for which spirometry measurement would be contraindicated

Trial design

15 participants in 1 patient group

1

Description:

subjects with bronchiectasis